Type 1 interferons as a potential treatment against COVID-19

dc.creator	Sallard, Erwan
dc.creator	Lescure, François-Xavier
dc.creator	Yazdanpanah, Yazdan
dc.creator	Mentre, France
dc.creator	Peiffer-Smadja, Nathan
dc.date.accessioned	2020-05-25T20:29:10Z
dc.date.available	2020-05-25T20:29:10Z
dc.date.issued	2020-06
dc.description.abstract	Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19.	pt_BR
dc.identifier.citation	SALLARD, E. et al. Type 1 interferons as a potential treatment against COVID-19. Antiviral Research, [S.l.], v. 178, June 2020.	pt_BR
dc.identifier.uri	https://repositorio.ufla.br/handle/1/41214
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S0166354220302059	pt_BR
dc.language	en_US	pt_BR
dc.publisher	Elsevier	pt_BR
dc.rights	openAccess	pt_BR
dc.source	Antiviral Research	pt_BR
dc.subject	Interferon	pt_BR
dc.subject	COVID-19	pt_BR
dc.subject	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)	pt_BR
dc.title	Type 1 interferons as a potential treatment against COVID-19	pt_BR
dc.type	Artigo	pt_BR

Arquivos

Agora exibindo 1 - 1 de 1